Which has the lower trailing P/E, ENSG or GMED?

GMED has the lower trailing P/E: ENSG trades at 27.20 and GMED at 21.22. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ENSG or GMED?

Over the past five years, GMED grew revenue faster — ENSG at a 17.08% CAGR versus GMED at 27.65%.

Does ENSG or GMED pay a bigger dividend?

ENSG pays a dividend (0.15% yield), while GMED has no payments in the available dividend history.

Is ENSG or GMED more profitable?

GMED runs the higher net margin — ENSG at 6.90% versus GMED at 17.03%.

How have ENSG and GMED total returns compared?

Over the past 10 years, ENSG delivered 26.44% and GMED delivered 13.76% annualized total return. Past performance doesn't predict future results.

The Ensign Group, Inc. (ENSG) vs Globus Medical, Inc. (GMED)

A side-by-side comparison of The Ensign Group, Inc. and Globus Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

ENSG

The Ensign Group, Inc.

$10.11B

$173.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

GMED

Globus Medical, Inc.

$11.13B

$82.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — ENSG vs GMED

growth of $100 · dividends reinvested · last 10y

ENSG +934.1% (+26.3%/yr)GMED +267.7% (+13.9%/yr)ENSG compounded faster over this window

ENSG GMED

ENSG vs GMED: by the numbers

•GMED is the larger company ($11.13B vs $10.11B market cap).
•GMED trades at the lower trailing earnings multiple (21.22 vs 27.20 P/E), one valuation lens rather than an overall verdict.
•GMED converts more revenue to profit (17.03% vs 6.90% net margin).
•GMED grew revenue faster over the past five years (27.65% vs 17.08% CAGR).
•ENSG pays a dividend (0.15% yield), while GMED has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ENSG	GMED
P/E ratio	27.20	21.22
Forward P/E	22.26	16.57
P/S ratio	1.88	3.63
P/B ratio	4.23	2.39
EV / EBITDA	21.15	11.79
FCF yield	4.06%	6.58%

Profitability

Metric	ENSG	GMED
Gross margin	14.14%	68.55%
Operating margin	8.52%	20.75%
Net margin	6.90%	17.03%
ROE	15.51%	11.23%
ROIC	7.29%	10.49%

Dividends

Metric	ENSG	GMED
Dividend yield	0.15%	N/A
Payout ratio	4.29%	N/A

Growth (annualized)

Metric	ENSG	GMED
Revenue CAGR (5Y)	17.08%	27.65%
EPS CAGR (5Y)	13.47%	30.79%
FCF CAGR (5Y)	10.84%	29.93%
Total return CAGR (5Y)	16.34%	0.22%

Frequently asked

Which has the lower trailing P/E, ENSG or GMED?: GMED has the lower trailing P/E: ENSG trades at 27.20 and GMED at 21.22. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ENSG or GMED?: Over the past five years, GMED grew revenue faster — ENSG at a 17.08% CAGR versus GMED at 27.65%.
Does ENSG or GMED pay a bigger dividend?: ENSG pays a dividend (0.15% yield), while GMED has no payments in the available dividend history.
Is ENSG or GMED more profitable?: GMED runs the higher net margin — ENSG at 6.90% versus GMED at 17.03%.
How have ENSG and GMED total returns compared?: Over the past 10 years, ENSG delivered 26.44% and GMED delivered 13.76% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ENSG analysis Full GMED analysis Interactive comparison tool

Dig into the metrics

Ensign P/E ratio Globus Medical P/E ratio Ensign dividend yield Ensign ROE Globus Medical ROE Ensign operating margin Globus Medical operating margin Ensign revenue growth Globus Medical revenue growth Ensign free cash flow Globus Medical free cash flow

Ensign & Globus Medical appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.